Om Elmasryeen Genral Hospital
Giza, Egypt
Location status: Recruiting
NCT Number: NCT06822218
the results of this study may provide an easy non pharmacological modality for dealing with diabetic polyneuropathic pain. Also, the outcome of this study will guide physiotherapists to develop a new noninvasive treatment modality that may improve patient symptoms and promotes their social participation , this in turn may add to clinical role played by therapists in management of diabetic polyneuropathy. In Addition, increased knowledge of the influence of High tone power therapy on neuropathic pain
Interested in participating?
Request Info50 year–60 year
Male
Interventional
Not applicable
Giza, Egypt
Location status: Recruiting
This study will be carried out on sixty diabetic male patients with polyneuropathy with ages 50-60 years . Patient will be randomly assigned to two grouos. group A will include 30 type 2 diabetic patients with diabetic polyneuropathy. Theses patients will receive High tone power therapy with Frequencies continuously will be scanned from 4096 Hz to 31768 Hz, allowing for a much higher power of up to 5000 mW to be introduced for 3 times per week, for 3 months for 30 minutes every session.
Group B :
This group will include 30 type 2 diabetic patients with diabetic neuropathy. These patients will receive TENS with applied frequencies range from 2 to 120 Hz. for 3 times per week for 30 minutes every session during 3 months of intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients will be assigned into 2 groups with pre and post treatment protocol application. all patients will be thoroughly evaluated before and after treatment protocol application.
These patients will receive TENS with applied frequencies range from 2 to 120 Hz. for 3 times per week for 30 minutes every session during 3 months of intervention in addition to medications.
Time frame: up to 12 weeks
t is a questionnaire has been developed to facilitate detection of neuropathic pain.total score is 10 .diagnosis of neuropathic pain is 4/10.
Time frame: up to 12 weeks
devices that can be used to identify the pressure and/or force eliciting a pressure-pain threshold. It has been noted in pressure
Time frame: up to 12 weeks
Increasing HbA1c level is significantly associated with increased prevalence of DPN as well as PDPN and non-painful DPN
Time frame: up to 12 weeks
the World Health Organization Quality of Life Brief Version (WHOQOL-BREF) is an abbreviated, 26-item version of the 100-item WHOQOL-100 quality of life measure. The WHOQOL-BREF addresses four quality of life domains: physical health, psychological health, social relationships and environment. Then calculate a domain score for each of the health domains by calculating the average answer points for each domain (sum of answer points divided by number of questions) and multiplying the result by the number 4.
Contact information is provided by the study sponsor or research team.
Alaa El-Moatasem, lecturer
CONTACT
zeinab Awadallah, master
CONTACT
Cairo University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07605572
Cornea, Corneal Diseases
Athens, Greece
View Trial DetailsNCT07604493
Behavior, Diabete Mellitus
Roma, RM, Italy
View Trial DetailsNCT07550777
Age Macular Degeneration, Butyrylcholinesterase deficiency
Erzurum, Turkey (Türkiye)
View Trial DetailsNCT07378956
Cardiovascular Diseases, Diabete Mellitus
Incheon, Gyeonggi-do, South Korea
View Trial Details